Socio-psychological factors associated with anticipated stigma toward COVID-19: a cross-sectional study in Japan.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
27 06 2023
Historique:
received: 02 11 2022
accepted: 20 06 2023
medline: 29 6 2023
pubmed: 28 6 2023
entrez: 27 6 2023
Statut: epublish

Résumé

The stigmatization against COVID-19 has become a public issue. However, it remains unknown which individual factor contributes to anticipated stigma formation. This study explored socio-psychological factors associated with anticipated stigma toward coronavirus disease 2019 (COVID-19). We obtained cross-sectional data regarding 1,638 middle-aged community residents (mean age, 48.5 years) from a population-based survey in metropolitan Tokyo, Japan during the third wave of the COVID-19 pandemic, when a regional public health emergency had been declared in December 2020 and January 2021. We hypothesized that perceived risk of infection, normative beliefs about preventive behaviors, and past experiences of stigmatization unrelated to COVID-19 would be associated with anticipated stigma. Modified Poisson regression was conducted to examine associations after adjustments for demographic and socioeconomic statuses. Higher perceived risk (adjusted prevalence ratio [APR] = 1.17; 95% confidence interval [CI, 1.08-1.27]), past experiences of stigmatization (APR = 1.09; 95% CI [1.00-1.19]), and higher normative beliefs about preventive behaviors (APR = 1.18; 95% CI [1.11-1.26]) were independently associated with anticipated stigma. These results suggest that intervention messages to increase risk perception and normative beliefs to enhance protective behaviors may have the unintended effect of increasing anticipated stigma in the context of the COVID-19 pandemic.

Sections du résumé

BACKGROUND
The stigmatization against COVID-19 has become a public issue. However, it remains unknown which individual factor contributes to anticipated stigma formation. This study explored socio-psychological factors associated with anticipated stigma toward coronavirus disease 2019 (COVID-19).
METHODS
We obtained cross-sectional data regarding 1,638 middle-aged community residents (mean age, 48.5 years) from a population-based survey in metropolitan Tokyo, Japan during the third wave of the COVID-19 pandemic, when a regional public health emergency had been declared in December 2020 and January 2021. We hypothesized that perceived risk of infection, normative beliefs about preventive behaviors, and past experiences of stigmatization unrelated to COVID-19 would be associated with anticipated stigma. Modified Poisson regression was conducted to examine associations after adjustments for demographic and socioeconomic statuses.
RESULTS
Higher perceived risk (adjusted prevalence ratio [APR] = 1.17; 95% confidence interval [CI, 1.08-1.27]), past experiences of stigmatization (APR = 1.09; 95% CI [1.00-1.19]), and higher normative beliefs about preventive behaviors (APR = 1.18; 95% CI [1.11-1.26]) were independently associated with anticipated stigma.
CONCLUSIONS
These results suggest that intervention messages to increase risk perception and normative beliefs to enhance protective behaviors may have the unintended effect of increasing anticipated stigma in the context of the COVID-19 pandemic.

Identifiants

pubmed: 37370015
doi: 10.1186/s12889-023-16159-9
pii: 10.1186/s12889-023-16159-9
pmc: PMC10294524
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1245

Informations de copyright

© 2023. The Author(s).

Références

Clin J Pain. 2021 May 1;37(5):349-358
pubmed: 33734147
Br J Health Psychol. 2020 Nov;25(4):981-1005
pubmed: 32780891
Dig Dis Sci. 2010 Apr;55(4):1044-52
pubmed: 20155319
J Health Soc Behav. 1995 Mar;36(1):38-56
pubmed: 7738327
Lancet Infect Dis. 2020 Jul;20(7):782
pubmed: 32592670
Sociol Health Illn. 2015 Nov;37(8):1218-35
pubmed: 26139357
AIDS Behav. 2012 Apr;16(3):525-34
pubmed: 22327408
J Nerv Ment Dis. 2017 Oct;205(10):801-804
pubmed: 28961595
J Pers Soc Psychol. 2009 Oct;97(4):634-51
pubmed: 19785483
Patient Educ Couns. 2022 Jul;105(7):2504-2511
pubmed: 34916096
BMJ Open Diabetes Res Care. 2016 Jan 05;4(1):e000156
pubmed: 26835138
Br J Clin Psychol. 2010 Mar;49(Pt 1):31-41
pubmed: 19298685
Ann Behav Med. 2021 Jul 22;55(8):805-812
pubmed: 34228112
Emerg Infect Dis. 2004 Aug;10(8):1486-9
pubmed: 15496256
Ann Behav Med. 2020 Oct 1;54(10):738-746
pubmed: 32909031
Health Educ Behav. 2021 Aug;48(4):434-445
pubmed: 33823626
Intern Emerg Med. 2020 Mar;15(2):211-223
pubmed: 31893346
J Aging Health. 2021 Aug-Sep;33(7-8):577-584
pubmed: 33779385
Brain Behav Immun. 2020 Oct;89:555-558
pubmed: 32731007
Soc Sci Med. 2017 Mar;177:223-230
pubmed: 28192711
J Health Soc Behav. 1998 Dec;39(4):335-47
pubmed: 9919855
Indian J Tuberc. 2020 Jul;67(3):284-285
pubmed: 32825854
Int J Infect Dis. 2020 Oct;99:312-323
pubmed: 32768695
J Epidemiol. 2014;24(4):334-44
pubmed: 24814507
Int J Environ Res Public Health. 2020 Sep 19;17(18):
pubmed: 32961702
BMJ. 2021 Jan 15;372:n141
pubmed: 33451992
AIDS Care. 2016;28(5):585-90
pubmed: 26644042
J Behav Med. 2013 Jun;36(3):270-82
pubmed: 22526525
BMJ Open. 2020 Dec 30;10(12):e046620
pubmed: 33380488
Acad Psychiatry. 2008 Mar-Apr;32(2):98-103
pubmed: 18349328
J Clin Nurs. 2003 Jan;12(1):149-50
pubmed: 12519263
Stigma Health. 2016 Nov;1(4):225-243
pubmed: 28083562
AIDS Patient Care STDS. 2013 Nov;27(11):621-7
pubmed: 24138486
Am J Epidemiol. 2004 Apr 1;159(7):702-6
pubmed: 15033648
AIDS Behav. 2009 Dec;13(6):1160-77
pubmed: 19636699
Diabet Med. 2021 Jan;38(1):e14387
pubmed: 32799378
Asian J Psychiatr. 2020 Aug;52:102066
pubmed: 32302935
BMC Med. 2019 Feb 15;17(1):31
pubmed: 30764826
Int J Soc Psychiatry. 2020 Aug;66(5):512-516
pubmed: 32434402
J Health Psychol. 2012 Mar;17(2):157-68
pubmed: 21799078
Psychol Serv. 2015 Feb;12(1):49-58
pubmed: 25365245
Brain Behav Immun Health. 2020 Jul;6:100101
pubmed: 32835297
AIDS Behav. 2021 May;25(5):1423-1437
pubmed: 32737818
PLoS One. 2014 May 09;9(5):e96977
pubmed: 24817189

Auteurs

Kana Fujii (K)

Department of Health and Social Behavior, The University of Tokyo School of Public Health, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan. fujii-kana228@g.ecc.u-tokyo.ac.jp.

Hideki Hashimoto (H)

Department of Health and Social Behavior, The University of Tokyo School of Public Health, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH